Andexanet alfa versus Prothrombin Complex Concentrate for Direct Anticoagulation Reversal in Intracranial Hemorrhage: A Comparative Effectiveness Study
In a retrospective study of patients with intracranial hemorrhage on factor Xa inhibitors, andexanet alfa was associated with a higher rate of significant hemorrhage growth compared to 4-factor prothrombin complex concentrate, while both treatments showed similar outcomes regarding neurological deterioration, thromboembolic events, and mortality.